← Browse by Condition
Medical Condition

relapsed pediatric all

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT03938987 Phase 1, Phase 2
Recruiting

Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)

Enrollment
63 pts
Location
Canada
Sponsor
University of Alberta
View Trial →